Biomarker-Driven Lung Cancer Care: Application of New Standards and the Latest Research

Deepen your understanding of the role of biomarkers in lung cancer treatment and learn how to apply recent biomarker data from key clinical trials in a webcast from a live symposium with associated downloadable slides and an expert commentary.

Share

Program Content

NSCLC: Molecular Testing
The Importance of Molecular Testing in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2022

Expires: June 04, 2023

View Activity
Less Common Driver Mutations in NSCLC
Selecting Therapy for Less Common Driver Mutations in Advanced Lung Cancer: MET, RET, ALK, ROS, NTRK
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2022

Expires: June 04, 2023

View Activity
NSCLC: <i>EGFR</i>, <i>KRAS</i>, and <i>HER2</i>
Treatment Options for the Common Targetable Biomarkers for Advanced NSCLC: EGFR, KRAS, and HER2
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2022

Expires: June 04, 2023

View Activity
Lung Biomarkers
Biomarker-Driven Lung Cancer Care: Application of New Standards and the Latest Research
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

View Activity
Advanced NSCLC: Biomarker Testing
2 Patients From My Practice Who Illustrate the Importance of Biomarker Testing For Advanced NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 23, 2022

Expires: September 22, 2023

View Activity

Faculty

cover img faculity

Todd M. Bauer, MD

Senior Investigator, Drug Development
Sarah Cannon Research Institute
Tennessee Oncology, PLLC
Nashville, Tennessee

cover img faculity

Narjust Duma, MD

Associate Director of the Cancer Care Equity Program
Thoracic Oncologist
The Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Brigham and Women’s Hospital
Boston, Massachusetts

cover img faculity

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Lilly

Novartis Pharmaceuticals Corporation

Turning Point Therapeutics Inc